The Galien Forum USA 2020

COVID-19 Vaccine Development and the Enduring Impact on Life Sciences Innovation –  Speed, Collaboration, Clinical Trial Advancement and Manufacturing


The ongoing COVID-19 pandemic has underscored and continues to highlight the critical need for the life science industry to lead us through public health crises and address unmet needs in the advancement of human health. With unprecedented innovation, novel partnerships, visionary leadership, and unparalleled speed, our panelists and their respective companies are at the forefront of COVID-19 solutions and represent a beacon of hope in a path to reopening schools and businesses and resuming daily life.

Today’s panelists are renowned thought leaders behind two of the most promising COVID-19 vaccine candidates. They, alongside their organizations, are committed to bringing a safe and effective vaccine to FDA approval and scaling manufacturing to provide widespread access. Please join us for a discussion on their respective programs’ progress as well as the applied learnings and long-standing impact for future innovation in the life science industry with regard to speed of innovation, collaboration, clinical trial advancement, and manufacturing.